Scholars Central

Conference abstractPublished 23 Sep 2024

Method Development and Validation for Simultaneous Estimation of Aspirin and

Authors: G.Amani

India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The aim of this study was to develop and validate a reliable and efficient RP-HPLC method for the simultaneous estimation of Aspirin and Dipyridamol in capsule dosage forms.The objective was to establish a simple, rapid, and accurate chromatographic method to quantify Aspirin and Dipyridamol simultaneously in pharmaceutical formulations, ensuring its suitability for routine quality control analysis.The method was developed using a Shimadzu HPLC system equipped with a C18 column (250 mm × 4.6 mm, 5 μm). The mobile phase consisted of a mixture of phosphate buffer (pH 3.0) and methanol in a 60:40 (v/v) ratio, with a flow rate of 1.2 mL/min. Detection was carried out at 254 nm. The retention times for Aspirin and Dipyridamol were found to be 4.2 and 6.5 minutes, respectively. The method was validated for linearity, accuracy, precision, specificity, robustness and system suitability in accordance with ICH guidelines.The method demonstrated linearity in the concentration ranges of 10–100 μg/mL for Aspirin and 5–50 μg/mL for Dipyridamol, with correlation coefficients (R²) exceeding 0.999 for both compounds. The accuracy of the method was confirmed with recovery values ranging from 98% to 102%. Precision was validated with RSD values of less than 2% for intra-day and inter-day variations. The method was found to be specific with no interference from excipients in the capsule formulations and robustness testing showed reliable performance under slight variations in chromatographic conditions.The developed RP-HPLC method provides an efficient, accurate, and precise approach for the simultaneous estimation of Aspirin and Dipyridamol in capsules. This validated method is suitable for routine quality control and can be used for the analysis of these drugs in pharmaceutical formulations .

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “G.Amani”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels